Antibodies specific to the HA2 glycopolypeptide of influenza A virus haemagglutinin with fusion-inhibition activity contribute to the protection of mice against lethal infection

Journal of General Virology

Volumn 88, Issue 3, 2007, Pages 951-955

  Gocnik M ^a   Fislova T ^a   Sladkova T ^a   Mucha, V ^a   Kostolansky F ^a   Vareckova E ^a  

^a INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEMAGGLUTININ; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CB8; MONOCLONAL ANTIBODY CF2; MONOCLONAL ANTIBODY FE1; MONOCLONAL ANTIBODY HA2 GLYCOPOLYPEPTIDE; MONOCLONAL ANTIBODY IIF4; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; INFLUENZA; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS RECOMBINATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; HEMAGGLUTININS, VIRAL; HUMANS; IMMUNIZATION, PASSIVE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; LUNG; MICE; MICE, INBRED BALB C; VIRUSES;

INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE;

EID: 33847623088     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82563-0     Document Type: Article

References (34)

1. Becht H., Huang, R. T. C., Fleischer, B., Boschek, C. B. & Rott, R. (1984). Immunogenic properties of the small chain HA2 of the haemagglutinin of influenza viruses. J Gen Virol 65, 173-183.
2. Bystrická, M., Petríková, M., Zat'ovičová, M, Solárikoviá, L, Kostolansý, F., Mucha, V. & Russ, G. (1997). Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection. Acta Virol 41, 5-12.
3. Cox, N. J., Tamblyn, S. E. & Tam, T. (2003). Influenza pandemic planning. Vaccine 21, 1801-1803.
4. Ey, P. L., Prowse, S. J. & Jenkin, C. R. (1978). Isolation of pure IgGI, IgG2a and IgG2b immunoglobulins from mouse serum using Protein A-Sepharose. Immunochemistry 15, 429-436.
5. Fislová, T., Sládková, T., Gocnik, M., Mucha, V., Varečková, E. & Kostolansý, F. (2005). Differences in antibody responses of mice to intranasal or intraperitoneal immunization with influenza A virus and vaccination with subunit influenza vaccine. Acta Virol 49, 243-250.
6. Gerhard, W. (2001). The role of the antibody response in influenza virus infection. Curr Top Microbiol Immunol 260, 171-190.
7. Gould, K G., Scotney, H., Townsend, A. R., Bastin, J. & Brownlee, G. G. (1987). Mouse H-2k-restricted cytotoxic T cells recognize antigenic determinants in both the HAI and HA2 subunits of the influenza A/PR/8/34 hemagglutinin. J Exp Med 166, 693-701.
8. + T cells within the light chain of the H3 hemagglutinin molecule of influenza virus. Virology 198, 613-623.
9. Katz, J. M., Brown, L E., Ffrench, R. A. & White, D. O. (1985). Murine helper T lymphocyte response to influenza virus: Recognition of haemagglutinin by subtype-specific and cross-reactive T cell clones. Vaccine 3, 257-262.
10. Knossow, M., Gaudier, M, Douglas, A., Barrere, B, Bizebard, T., Barbey, C., Gigant, B. & Skehel, J. J. (2002). Mechanism of neutralization of influenza virus infectivity by antibodies. Virology 302, 294-298.
11. Kostolansý, F., Mucha, V., Slováková, R. & Varečková, E. (2002). Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide. Acta Virol 46, 229-236.
12. Kuwano, K., Scott, M, Young, J. F. & Ennis, F. A. (1988). HA2 subunit of influenza A H1 and H2 subtype induces a protective cross-reactive cytotoxic T lymphocyte response. J Immunol 140, 1264-1268.
13. Mbawuike, I. N., Dillion, S. B., Demuth, S. G., Jones, C. S., Cate, T. R. & Couch, R. B. (1994). Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein. Vaccine 12, 1340-1348.
14. Mitchell, J. A., Green, T. D., Bright, R. A. & Ross, T. M. (2003). Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. Vaccine 21, 902-914.
15. Mozdzanowska, K., Feng, J., Eid, M., Kragol, G., Cudic, M., Otvos, L., Jr & Gerhard, W. (2003). Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine 21, 2616-2626.
16. Nobusawa, E., Aoyama, T., Kato, H., Suzuki, Y., Tateno, Y. & Nakajima, K (1991). Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 182, 475-485.
17. Okuno, Y., Isegawa, Y., Sasao, F. & Ueda, S. (1993). A common neutralizing epitope conserved between the hernagglutinins of influenza A virus H1 and H2 strains. J Virol 67, 2552-2558.
18. Okuno, Y., Matsumoto, K, Isegawa, Y. & Ueda, S. (1994). Protection against the mouse-adapted A/FM/1/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among H1 and H2 strains. J Virol 68, 517-520.
19. Russ, G., Poláková, K, Kostolanský, F., Styk, B. & Vančíková, M. (1987). Monoclonal antibodies to glycopeptides HA1 and HA2 of influenza virus hernagglutinin. Acta Virol 31, 374-386.
20. Saikh, K. U., Martin, J. D., Nishikawa, A. H. & Dillon, S. B. (1995). Influenza A virus-specific H2d restricted cross-reactive cytotoxic T lymphocyte epitope(s) detected in the hemagglutinin HA2 subunit of A/ Udorn/72. Virology 214, 445-452.
21. Sánchez-Fauquier, A., Villanueva, N. & Melero, J. A. (1987). Isolation of cross-reactive, subtype-specific monoclonal antibodies against influenza virus HA1 and HA2 hemagglutinin subunits. Arch Virol 97, 251-265.
22. Sáchez-Fauquier, A., Guillen, M., Martin, J., Kendal, A. P. & Melero, J. A. (1991). Conservation of epitopes recognized by monoclonal antibodies against the separated subunits of influenza hemagglutinin among type A viruses of the same and different subtypes. Arch Virol 116, 285-292.
23. Skehel, J. J. & Wiley, D. C. (2000). Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu Rev Biochem 69, 531-569.
24. Smirnov, Y. A., Lipatov, A. S., Gitelman, A. K, Claas, E C. & Osterhaus, A. D. (2000). Prevention and treatment of broncho-pneumonia in mice caused by mouse-adapted variant of avian H5N2 influenza A virus using monoclonal antibody against conserved epitope in the HA stem. Arch Virol 145, 1733-1741.
25. Spier, R. E (2005). On the need for, and the delivery of, cross-protective vaccines. Vaccine 23, 2027-2029.
26. Styk, B., Russ, G. & Poláková, K (1979). Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. III. Reactivity with human convalescent sera. Acta Virol 23, 1-8.
27. Tamura, M., Webster, R. G. & Ennis, F. A. (1994). Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses. J Virol 68, 3499-3504.
28. Tamura, S., Tanimoto, T. & Kurat, T. (2005). Mechanism of broad cross-protection provided by influenza virus infection and their application to vaccines. Jpn J Infect Dis 58, 195-207.
29. Tkáčová, M., Varečková, E., Baker, I. C., Love, J. M. & Ziegler, T. (1997). Evaluation of monoclonal antibodies for subtyping of currently circulating human type A influenza viruses. J Clin Microbiol 35, 1196-1198.
30. Varečková, E., Cox, N. & Klimov, A. (2002). Evaluation of the subtype specificity of monoclonal antibodies raised against H1 and H3 subtypes of human influenza A virus hemagglutinins. J Clin Microbiol 40, 2220-2223.
31. Varečtová, E, Mucha, V., Wharton, S. A. & Kostolanský, F. (2003a). Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies. Arch Virol 148, 469-486.
32. Varečková, E., Wharton, S. A, Mucha, V, Gocnik, M. & Kostolanský, F. (2003b). A monoclonal antibody specific to the HA2 glycoprotein of influenza A virus hemagglutinin that inhibits its fusion activity reduces replication of the virus. Acta Virol 47, 229-236.
33. Varečková, E., Blaškovičová, H., Gocnik, M., Mikas, J., Adamčáková, J., Fislová, T., Kostolanský, F. & Mucha, V. (2006). Evaluation of clinical specimens for influenza A virus positivity using various diagnostic methods. Acta Virol 50, 181-186.
34. Wabuke-Bunoti, M. A., Taku, A., Fan, D. P., Kent, S. & Webster, R. G. (1984). Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin. J Immunol 133, 2194-2201.